AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meador, T. L.
Right arrow Articles by McLarney, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meador, T. L.
Right arrow Articles by McLarney, J. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2000; 175:115-118
© American Roentgen Ray Society


Original Report

CT Features of Castleman Disease of the Abdomen and Pelvis

Toni L. Meador1,2 and John K. McLarney1,3

1 Department of Radiologic Pathology, Armed Forces Institute of Pathology, Rm. M-111, 14th St. N.W. and Alaska Ave., Washington, DC 20306-6000.
2 Present address: Asheville Radiology Associates, P. O. Box 2959, Asheville, NC 28802.
3 Present address: Department of Radiology, USA MEDDAC, Fort Carson, CO 80913.

OBJECTIVE. The purpose of this study was to describe the CT features of Castleman disease in the abdomen and pelvis.

CONCLUSION. The most frequent appearance of abdominal or pelvic Castleman disease is of a single, well-defined enhancing mass. Smaller tumors (<5 cm) display homogeneous contrast enhancement; larger tumors (>5 cm) show heterogeneous enhancement and attenuation when correlated with central necrosis and degeneration. Calcification was seen in 31% of the cases. Castleman disease may be considered in the differential diagnosis of a discrete enhancing mass in the abdomen or pelvis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S.-F. Ko, M.-J. Hsieh, S.-H. Ng, J.-W. Lin, Y.-L. Wan, T.-Y. Lee, W.-J. Chen, and M.-C. Chen
Imaging Spectrum of Castleman's Disease
Am. J. Roentgenol., March 1, 2004; 182(3): 769 - 775.
[Full Text] [PDF]


Home page
Br. J. Radiol.Home page
S D Chang and R F Thoeni
Castleman's disease presenting as an adnexal mass: ultrasound, CT and MRI features
Br. J. Radiol., February 1, 2004; 77(914): 161 - 163.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A. Nishie, K. Yoshimitsu, H. Irie, H. Aibe, T. Tajima, K. Shinozaki, T. Nakayama, D. Kakihara, S. Naito, M. Ono, et al.
Radiologic Features of Castleman's Disease Occupying the Renal Sinus
Am. J. Roentgenol., October 1, 2003; 181(4): 1037 - 1040.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Roentgen Ray Society.